Detroit Cardiologists
Get Directions Southfield - (248) 424-5000   15565 Northland Drive | Suite 108E | Southfield, MI 48075 Hours | Mon – Sat | 7:30 am – 5:00 pm Toll Free | (855) 543-2783   (855) 5-HEARTDOCS - Fax | (248) 424-5099 Doctors Available 24/7 for Emergencies | (313) 222-0330
Detroit Heart Doctors
Get Directions Dearborn - (313) 791-3000 Dearborn Professional Building 2421 Monroe Street | Suite 101 | Dearborn, MI 48124 Hours | Mon – Sat | 7:30 am – 5:00 pm Toll Free | (855) 543-2783   (855) 5-HEARTDOCS - Fax | (313) 791-2800 Doctors Available 24/7 for Emergencies | (313) 222-0330
Detroit Heart Surgeons
Get Directions Detroit - (313) 993-7777   4160 John R Street | Suite 510 | Detroit, MI 48201 Hours | Mon – Sat | 7:30 am – 5:00 pm Toll Free | (855) 543-2783   (855) 5-HEARTDOCS - Fax | (313) 993-2563 Doctors Available 24/7 for Emergencies | (313) 222-0330
  • More
  • Southfield
    (248) 424-5000
  • More
  • Dearborn
    (313) 791-3000
  • More
  • Detroit
    (313) 993-7777
24/7 EMERGENCY (313) 222-0330

Medical News

DMC Heart Hospital first in U.S. to use new device

Monday, October 13, 2014
DMC Heart Hospital first in U.S. to use new device to treat vascular disease
FDA approves first drug-coated angioplasty balloon catheter

The Detroit Medical Center (DMC) today announced Drs. Theodore Schreiber and Mahir Elder and are first in the country to use the Lutonix ® 035 Drug Coated Balloon PTA Catheter (DCB), the first and only DCB approved by the U.S. Food and Drug Administration (FDA).

"This demonstrates the dedication of DMC Heart Hospital to provide cutting edge technology which is cost effective in combating cardiovascular disease," said President of DMC Heart Hospital Dr. Schreiber. "This advanced technology is first available at DMC Heart Hospital."

When a Detroit patient with advanced Peripheral Arterial Disease (PAD) arrived at the DMC Heart Hospital complaining of severe leg pains, Dr. Elder, DMC Heart Hospital's Medical Director of Endovascular Medicine, quickly examined her and discovered that the superficial femoral artery in one of her legs had an 85-percent blockage. Dr. Elder immediately decided to use the new Bard Lutonix drug-coated balloon Saturday, October 11 to remove the arterial blockage. In a painless procedure lasting only 30 minutes, he successfully employed the new device, completely removing the blockage and restoring the middle-aged Detroit patient's full leg function.

Dr. Elder, an award-winning physician who has in recent years performed thousands of successful procedures for patients with threatening arterial blockages of one kind or another, said "the procedure was quick and painless and the patient went home the next morning."

"This new tool is going to help PAD patients greatly, because the medication that is included on the balloon significantly enhances its ability to remove arterial blockages," he said. "This new non-surgical technology will help improve circulation in the leg." DMC Heart hospital is number one hospital in metro area treating PAD with minimally invasive techniques.

Peripheral Arterial Disease (PAD) in the femoropopliteal artery, a life-threatening condition, affects millions of Americans by narrowing arteries and reducing blood flow to the limbs, according to American Heart Association (AHA) estimates. Patients with PAD in the femoropopliteal arteries are at risk for lower-extremity amputation, particularly in people over the age of 50. Minimally-invasive endovascular procedures such as angioplasty balloons and stents, medications and vascular bypass surgery are some of the accepted ways to treat PAD, but these options may be limited depending on the type of arterial blockage.

Successful treatment of PAD requires improved blood flow (patency) for longer periods of time. A recent clinical study demonstrated superior primary patency with the Lutonix ® 035 DCB for the efficacy endpoint. The Lutonix ® 035 Drug Coated Balloon PTA Catheter (DCB) is the first and only DCB approved by the U.S. Food and Drug Administration (FDA) for percutaneous transluminal angioplasty, after pre-dilatation, of de novo or restenotic lesions up to 150mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-6mm.

To make a referral to a DMC Heart Specialist, please call 888-DMC-2500, or use the personalized Physician Scheduling Portal at www.dmc.org/prservices.

Source: View Article Source

Detroit Heart Doctors